STEPHANIE GARCIA: Open Payments
NPI 1588328280 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,511 in 76 payments from 22 companies in 2025. Trend: 2023 $832 · 2024 $946 · 2025 $1,511
Food & beverage: $1,511
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $243 |
| AstraZeneca Pharmaceuticals LP | 9 | $189 |
| Lilly USA, LLC | 10 | $167 |
| Novo Nordisk Inc | 4 | $153 |
| Axsome Therapeutics, Inc. | 5 | $144 |
| Astellas Pharma US Inc | 5 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $61 |
| Paratek Pharmaceuticals, Inc. | 2 | $36 |
| Antares Pharma, Inc. | 2 | $34 |
Products named: MOUNJARO, Wegovy, Auvelity, AIRSUPRA, Veozah, TRINTELLIX, QULIPTA, VRAYLAR.
Industry payments across TX — which companies pay providers there.
